RB

Rajesh Bhatia

Active Director Director DIN 00235249
DIN 00235249 First appointment Mar 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 1999
Shareholding value •••• Premium profile

About Rajesh Bhatia

Data last updated:

Rajesh Bhatia is a Director at Riemann Labs Private Limited (since 1999). The company operates in Pharma. Riemann Labs Private Limited reported revenue of ₹9.75 Cr (FY 2025).

DIN 00235249
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 1999
Oldest Company Age 27 yrs
Largest company Riemann Labs Private Limited · ₹9.75 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Riemann Labs Private Limited U24232MP1999PTC013404
Director18 Mar 19991999₹9.75 Cr (FY 2025)Active

Board colleagues of Rajesh Bhatia

Directorship timeline

Open interactive timeline →
Riemann Labs Private Limited
Premium access

Shareholding and investment profile for Rajesh Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Bhatia

Rajesh Bhatia currently holds 1 directorship: Riemann Labs Private Limited (Director, since 18 Mar 1999, revenue ₹9.75 Cr (FY 2025)).

Rajesh Bhatia was first appointed on 18 Mar 1999 as Director at Riemann Labs Private Limited.

The current boards of Rajesh Bhatia's companies include Chandan Bhatia (Riemann Labs Private Limited), Navin Bhatia (Riemann Labs Private Limited), Neeraj Bhatia (Riemann Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available